Literature DB >> 30292306

Recent advances in using mass spectrometry for mitochondrial metabolomics and lipidomics - A review.

Xinyu Liu1, Guowang Xu2.   

Abstract

Metabolomics and lipidomics generally targets a huge number of intermediate and end products of cellular metabolism in body fluids, tissues, and cells etc. At present, mass spectrometry (MS) based metabolic or lipid profiling of routine biological specimens including the whole cells, tissues, plasma, serum and urine etc., can cover hundreds of metabolites or lipid species in one analysis, which has qualified deep elucidation of global metabolic and lipid networks. Mitochondria are important intracellular organelles and many critical biochemical reactions occur here, they provide building block for new cells, control redox balance, participate in apoptosis and behave as a signalling platform. Evidence suggests high prevalence of mitochondrial dysfunction occurs in a variety of cancers and other diseases, thus there is an urgent demand for investigating and clarifying mitochondrial metabolic and lipid alterations induced by diseases. Nevertheless, mitochondria contribute a small fraction to cellular contents, profiling of whole cell is probably unsuitable for monitoring alterations in mitochondria. Therefore, metabolomics and lipidomics analyses specially for mitochondria are necessary to understand disturbed metabolic and lipid pathways induced by environment and diseases. However, methods for comprehensively profiling metabolites and lipids in mitochondria have been limited at present. This review summarizes the current states and progress of MS-based mitochondrial metabolomics and lipidomics study. Details of mitochondrial isolation procedure, analytical methods and their applications are described. The challenges and opportunities are also given.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Lipidomics; Mass spectrometry; Metabolic profiling; Metabolomics; Mitochondria

Mesh:

Substances:

Year:  2017        PMID: 30292306     DOI: 10.1016/j.aca.2017.11.080

Source DB:  PubMed          Journal:  Anal Chim Acta        ISSN: 0003-2670            Impact factor:   6.558


  3 in total

1.  Altered Metabolomic Profile in Patients with Peripheral Artery Disease.

Authors:  Ahmed Ismaeel; Marco E Franco; Ramon Lavado; Evlampia Papoutsi; George P Casale; Matthew Fuglestad; Constance J Mietus; Gleb R Haynatzki; Robert S Smith; William T Bohannon; Ian Sawicki; Iraklis I Pipinos; Panagiotis Koutakis
Journal:  J Clin Med       Date:  2019-09-14       Impact factor: 4.241

2.  Mitochondrial metabolomic profiling for elucidating the alleviating potential of Polygonatum kingianum against high-fat diet-induced nonalcoholic fatty liver disease.

Authors:  Xing-Xin Yang; Jia-Di Wei; Jian-Kang Mu; Xin Liu; Feng-Jiao Li; Yan-Qin Li; Wen Gu; Jing-Ping Li; Jie Yu
Journal:  World J Gastroenterol       Date:  2019-11-21       Impact factor: 5.742

3.  Role of mitochondria and cardiolipins in growth inhibition of breast cancer cells by retinoic acid.

Authors:  Mineko Terao; Laura Goracci; Valentina Celestini; Mami Kurosaki; Marco Bolis; Alessandra Di Veroli; Arianna Vallerga; Maddalena Fratelli; Monica Lupi; Alessandro Corbelli; Fabio Fiordaliso; Maurizio Gianni; Gabriela Paroni; Adriana Zanetti; Gabriele Cruciani; Enrico Garattini
Journal:  J Exp Clin Cancer Res       Date:  2019-10-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.